Central Garden & Pet
CENT · Household Products
$45.38
0.6%Colgate-Palmolive
CL · Household Products
$94.04
3.4%The short version
- Colgate-Palmolive is the larger business, with $20.4B of revenue in fiscal 2025 against $3.1B for Central Garden & Pet, about 6.5 times as much.
- Colgate-Palmolive grew revenue faster (1.4%, against −2.2%).
- Colgate-Palmolive kept more of each dollar of sales as operating profit (16.2% operating margin, against 8.0% operating margin).
- Colgate-Palmolive turned more of its sales into free cash flow (17.8% FCF margin, against 9.3% FCF margin).
- Colgate-Palmolive earned a higher return on the capital invested in it (37.3%, against 9.7%).
- Investors pay more for each dollar of Colgate-Palmolive’s earnings: a P/E of 37.2x against 16.8x for Central Garden & Pet.
| Latest fiscal year | CENT · FY25 | CL · FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.8B | $75.4B |
| Revenue | $3.1B | $20.4B |
| Free cash flow | $291M | $3.6B |
| Net income | $163M | $2.1B |
| Growth | ||
| Revenue growth | −2.2% | 1.4% |
| 5-year growth | 3.0% | 4.4% |
| Share count change | −4.6% | −1.5% |
| Profitability | ||
| Gross margin | 31.9% | 60.1% |
| Operating margin | 8.0% | 16.2% |
| Net margin | 5.2% | 10.5% |
| FCF margin | 9.3% | 17.8% |
| Return on capital | 9.7% | 37.3% |
| Return on equity | 10.4% | — |
| Balance sheet | ||
| Net debt | $309M | $6.4B |
| Net debt / EBITDA | 0.9x | 1.6x |
| Dividends and buybacks | $155M | $3.0B |
| Valuation & quality | ||
| P/E | 16.8x | 37.2x |
| Piotroski F-score | 8 | 5 |
FY16
CENT $1.8B
CL $15.2B
FY17
CENT $2.1B
CL $15.5B
FY18
CENT $2.2B
CL $15.5B
FY19
CENT $2.4B
CL $15.7B
FY20
CENT $2.7B
CL $16.5B
FY21
CENT $3.3B
CL $17.4B
FY22
CENT $3.3B
CL $18.0B
FY23
CENT $3.3B
CL $19.5B
FY24
CENT $3.2B
CL $20.1B
FY25
CENT $3.1B
CL $20.4B
CENT
CL
FY16
CENT 7.1%
CL 26.0%
FY17
CENT 7.6%
CL 24.0%
FY18
CENT 7.6%
CL 23.8%
FY19
CENT 6.4%
CL 22.7%
FY20
CENT 7.3%
CL 23.6%
FY21
CENT 7.7%
CL 19.1%
FY22
CENT 7.8%
CL 16.1%
FY23
CENT 6.4%
CL 20.5%
FY24
CENT 5.8%
CL 21.2%
FY25
CENT 8.0%
CL 16.2%
CENT
CL
FY16
CENT $124M
CL $2.5B
FY17
CENT $69.7M
CL $2.5B
FY18
CENT $76.3M
CL $2.6B
FY19
CENT $173M
CL $2.8B
FY20
CENT $221M
CL $3.3B
FY21
CENT $171M
CL $2.8B
FY22
CENT −$149M
CL $1.9B
FY23
CENT $328M
CL $3.0B
FY24
CENT $352M
CL $3.5B
FY25
CENT $291M
CL $3.6B
CENT
CL
FY16
CENT 9.9%
CL 50.9%
FY17
CENT 10.6%
CL 44.0%
FY18
CENT 15.1%
CL 49.2%
FY19
CENT 10.0%
CL 41.6%
FY20
CENT 13.5%
CL 41.1%
FY21
CENT 12.9%
CL 33.9%
FY22
CENT 9.2%
CL 26.5%
FY23
CENT 7.3%
CL 34.3%
FY24
CENT 6.9%
CL 45.9%
FY25
CENT 9.7%
CL 37.3%
CENT
CL
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.